Syed Sajjad
Internal Medicine · Levittown, PANPI 1962596130
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 320 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,388 and has fallen 98.2% since, to $25 in 2024. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 320 payments — averaging $15.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$530
- Pfizer$489
- GSK$441
- Merck$381
- AbbVie$353
- Novo Nordisk$284
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,80097%
- Education$1303%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $530 |
| Pfizer | 34 | $489 |
| GSK | 28 | $441 |
| Merck | 29 | $381 |
| AbbVie(2 entities) | 20 | $353 |
| Novo Nordisk | 18 | $284 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $275 |
| Amgen | 15 | $265 |
| Lilly USA, LLC | 17 | $234 |
| Sanofi-aventis U.S. LLC | 14 | $230 |
| Astellas Pharma US Inc | 8 | $201 |
| Vanda Pharmaceuticals Inc. | 7 | $161 |
| Eisai Inc. | 8 | $129 |
| Boehringer Ingelheim | 9 | $123 |
| Mylan Specialty L.p. | 9 | $119 |
| Otsuka America Pharmaceutical, Inc. | 6 | $104 |
| Johnson & Johnson | 7 | $94 |
| Amarin Pharma, Inc. | 7 | $94 |
| Scilex Pharmaceuticals Inc. | 5 | $78 |
| Arbor Pharmaceuticals, Inc. | 4 | $68 |
| Novartis | 4 | $51 |
| Ironwood Pharmaceuticals, Inc | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $27 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Abbott | 1 | $24 |
| Althera Pharmaceuticals LLC | 1 | $18 |
| Bayer | 1 | $18 |
| CMP Pharma, Inc. | 1 | $13 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,930 in reported general payments places this provider in the 90th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Levittown
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
- Ronak BhimaniNorristown$623K
- David GoldmannPhiladelphia$525K
- Christopher StillDanville$442K
- Jeffrey FreidLower Gwynedd$425K
- Cheryl PegusSpring House$370K
- Eyob FeyssaPhiladelphia$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.